Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-08-30

FDA Approved: ORPHENADRINE CITRATE — Original Application (Sagent Pharmaceuticals)

View source ↗

Summary

FDA approved Orphenadrine citrate under an Original Application for Sagent Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orphenadrine citrate (Orphenadrine citrate)

Snippet

ORIG AP for ORPHENADRINE CITRATE (ORPHENADRINE CITRATE)